Healthcare provider profile · identity verified

Stella C Tanedo, MD

Internal Medicine · EVERETT, WA · NPI 1790790582

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	967	277
Amlodipine Besylate	Amlodipine Besylate	561	155
Levothyroxine Sodium	Levothyroxine Sodium	474	135
Losartan Potassium	Losartan Potassium	466	134
Lisinopril	Lisinopril	358	106
Gabapentin	Gabapentin	289	86
Rosuvastatin Calcium	Rosuvastatin Calcium	278	80
Metoprolol Succinate	Metoprolol Succinate	253	67
Omeprazole	Omeprazole	199	51
Trazodone Hcl	Trazodone Hcl	196	55
Metformin Hcl Er	Metformin Hcl	177	55
Alendronate Sodium	Alendronate Sodium	171	53
Buspirone Hcl	Buspirone Hcl	164	48
Sertraline Hcl	Sertraline Hcl	162	42
Hydrochlorothiazide	Hydrochlorothiazide	161	47
Duloxetine Hcl	Duloxetine Hcl	155	44
Famotidine	Famotidine	146	48
Albuterol Sulfate Hfa	Albuterol Sulfate	144	61
Simvastatin	Simvastatin	143	38
Metformin Hcl	Metformin Hcl	142	43
Tamsulosin Hcl	Tamsulosin Hcl	119	34
Eliquis	Apixaban	106	22
Potassium Chloride	Potassium Chloride	104	29
Furosemide	Furosemide	102	35
Allopurinol	Allopurinol	99	30
Pantoprazole Sodium	Pantoprazole Sodium	99	25
Jardiance	Empagliflozin	97	29
Mirtazapine	Mirtazapine	95	23
Ozempic	Semaglutide	87	21
Fluoxetine Hcl	Fluoxetine Hcl	79	19
Carvedilol	Carvedilol	77	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	73	13
Metoprolol Tartrate	Metoprolol Tartrate	73	21
Fluticasone Propionate	Fluticasone Propionate	72	34
Escitalopram Oxalate	Escitalopram Oxalate	71	18
Atenolol	Atenolol	70	19
Glimepiride	Glimepiride	70	21
Montelukast Sodium	Montelukast Sodium	68	17
Citalopram Hbr	Citalopram Hydrobromide	63	15
Bupropion Xl	Bupropion Hcl	59	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	58	15
Tizanidine Hcl	Tizanidine Hcl	57	28
Quetiapine Fumarate	Quetiapine Fumarate	54	suppressed
Clopidogrel	Clopidogrel Bisulfate	53	14
Lovastatin	Lovastatin	51	16
Olmesartan Medoxomil	Olmesartan Medoxomil	49	11
Topiramate	Topiramate	48	17
Ropinirole Hcl	Ropinirole Hcl	47	suppressed
Spironolactone	Spironolactone	46	13
Synthroid	Levothyroxine Sodium	46	12
Triamcinolone Acetonide	Triamcinolone Acetonide	46	19
Oxybutynin Chloride Er	Oxybutynin Chloride	43	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	42	suppressed
Liothyronine Sodium	Liothyronine Sodium	41	suppressed
Pravastatin Sodium	Pravastatin Sodium	40	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	14
Oxycodone Hcl	Oxycodone Hcl	38	suppressed
Pregabalin	Pregabalin	37	16
Finasteride	Finasteride	36	12
Hydroxyzine Hcl	Hydroxyzine Hcl	36	13
Memantine Hcl	Memantine Hcl	35	suppressed
Acyclovir	Acyclovir	34	11
Glipizide Er	Glipizide	33	11
Hydralazine Hcl	Hydralazine Hcl	31	suppressed
Prednisone	Prednisone	31	22
Spiriva Handihaler	Tiotropium Bromide	31	suppressed
Estradiol	Estradiol	30	15
Meloxicam	Meloxicam	30	12
Azelastine Hcl	Azelastine Hcl	28	12
Lamotrigine	Lamotrigine	26	suppressed
Baclofen	Baclofen	25	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	23	suppressed
Clotrimazole	Clotrimazole	23	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Alprazolam	Alprazolam	22	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	22	suppressed
Cephalexin	Cephalexin	21	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	12
Ondansetron Odt	Ondansetron	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	14
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Nystatin	Nystatin	14	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Multaq	Dronedarone Hcl	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Digoxin	Digoxin	12	suppressed
Etodolac	Etodolac	12	suppressed
Irbesartan	Irbesartan	12	suppressed
M-Natal Plus	Pnv,calcium 72/Iron/Folic Acid	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Fluocinonide	Fluocinonide	11	suppressed
Lactulose	Lactulose	11	suppressed
Torsemide	Torsemide	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error